Home
Name
MOB
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for MOB
Name
Alternate Names
Chlorethazine Hydrochloride
Chlormethine Hydrochloride
Dichloromethyl-diethylamine-HCl
Mechlorethamine Hydrochloride
Meclorethamine
Mustargen
Mustargen-HCl
Mustine
Nitrogen Mustard
WR-147650
Valchlor
Abbreviations
HN2
NH2
NH2-HCl
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
000762
762
Primary Site
Histology
None
Remarks
FDA approved uses on bronchogenic carcinoma, chronic lymphocytic leukemia, Hodgkin's lymphoma, Non-Hodgkin lymphoma, lymphosarcoma, and malignant effusion.
Coding
This drug should be coded
Name
Alternate Names
Blenoxane
Bleo
Bleo-Cell
Bleo-S
Bleomycin for Injection
Bleomycin sulfate
Oil Bleo
Abbreviations
BLE
BLEO
BLM
Category
Chemotherapy
Subcategory
Antitumor antibiotic
NSC Number
125066
Primary Site
Histology
None
Remarks
Phase III melanoma Anti-tumor antibiotic; Genetronics. FDA approved uses on squamous cell cervical cancer, head & neck cancer, Hodgkin's and non-Hodgkin's lymphoma, nasopharyngeal cancer, carcinoma, and testicular cancer.
Coding
This drug should be coded
Name
Alternate Names
Compound 37231
Leurocristine Sulfate
Oncovin
Vincasar
Vincasar PFS
Vincristine Sulfate
Vincrystine
Vinkristin
Abbreviations
LCR
VCR
VNCR
Category
Chemotherapy
Subcategory
Plant alkyloid--antimetabolite
NSC Number
067574
67574
Primary Site
None
Histology
None
Remarks
Antineoplastic; vinca plant alkaloid; antimetabolite. FDA approved uses in ALL, Hodgkin's lymphoma, non-Hodgkin's lymphoma, neuroblastoma, rhabomyosarcoma, and Wilm's tumor.
Coding
This drug should be coded
